Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-75.37M
↑ 39% vs avg
Percentile
P64
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-122.93M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-75.37M | +40.9% |
| 2024 | $-127.63M | -37.6% |
| 2023 | $-92.72M | +38.0% |
| 2022 | $-149.67M | -32.7% |
| 2021 | $-112.83M | +29.6% |
| 2020 | $-160.38M | +16.0% |
| 2019 | $-191.03M | -18.3% |
| 2018 | $-161.48M | -118.9% |
| 2017 | $-73.78M | +12.6% |
| 2016 | $-84.46M | - |